Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.81B |
| Enterprise Value | 6.92B |
| P/E Ratio | 31.16 |
| PEG Ratio | 0.73 |
| Price/Sales Ratio | 5.01 |
| Price/Book Ratio | 4.84 |
| Enterprise/Revenue | 5.18 |
| Enterprise/EBITDA | 28.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 1.22B |
| Revenue/Share | 10.33 |
| Gross Profit | 634.32M |
| EBITDA | 277.26M |
| Net Income | 203.87M |
| Diluted EPS | 1.86 |
Balance Sheet
| Total Cash | 419.45M |
| Total Cash/Share | 3.66 |
| Total Debt | 574.03M |
| Total Debt/Equity | 0.46 |
| Current Ratio | 1.79 |
| Book Value Per Share | 11.06 |
Price History
| 52-Week Change | 15.32 |
| 52-Week High | 86.5 |
| 52-Week Low | 44.91 |
| Moving Average 50 Days | 56.81 |
| Moving Average 200 Days | 63.51 |
Statistics
| Average Volume | 2.23M |
| Shares Outstanding | 112M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.16 |
| Trailing Annual Dividend Yield | 0.31 |
| Payout Ratio | 0.15 |
| Last Split Factor | 7:5 |
| Last Split Date | May 12, 2023 |
AD
